With neurological disorders contributing nearly 10% to India’s total disease burden and ranking among the top causes of disability globally, the expansion of advanced neuro-care services is emerging as a critical component of the country’s healthcare ecosystem. Gurugram-based Medanta – The Medicity has strengthened its Deep Brain Stimulation (DBS) programme, widely known as ‘Brain Pacemaker’ surgery, reflecting the growing policy emphasis on specialised tertiary and quaternary care.
Recognised internationally and named Best Private Hospital in India by Newsweek for six consecutive years, Medanta’s DBS programme addresses advanced-stage Parkinson’s disease, dystonia, refractory epilepsy (adult onset), essential tremor and advanced obsessive-compulsive disorder (OCD), particularly in cases where conventional medication fails. The programme is led by Dr. Anirban Deep Banerjee, Director, Neurosurgery, Institute of Neurosciences at Medanta Gurugram, who has performed more than 300 DBS procedures over the past 15 years with consistently high success rates.
DBS involves implanting electrodes in targeted brain regions to regulate abnormal signals and restore motor function. Medanta integrates advanced imaging, directional leads for multi-dimensional neuromodulation, real-time brain-sensing biomarker feedback, AI-guided precision targeting and remote programming capabilities, underscoring increasing institutional investment in technology-driven, patient-specific neurological care aligned with evolving healthcare priorities.
